Decreased usage and increased effectiveness of percutaneous coronary intervention in complex older patients with

Mauro Di Bari1, Daniela Balzi2, Stefania Fracchia1

  • 1Department of Experimental and Clinical Medicine, Research Unit of Medicine of Aging, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Insights

Percutaneous coronary intervention (PCI) is underused in older acute coronary syndrome (ACS) patients due to background risk. However, PCI significantly improves survival in these individuals, especially those with higher risk scores.

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Health Services Research

Background:

  • Percutaneous coronary intervention (PCI) use is suboptimal in elderly patients with acute coronary syndromes (ACS).
  • Background risk factors may contribute to the underuse and reduced effectiveness of PCI in this population.
  • This study investigated the relationship between background risk and PCI utilization and outcomes in older ACS patients.

Purpose of the Study:

  • To determine if background risk influences PCI application in older ACS patients.
  • To assess the effectiveness of PCI in relation to background risk in this demographic.
  • To identify potential disparities in care for elderly ACS patients.

Main Methods:

  • An observational cohort study utilized data from the Acute Myocardial Infarction in Florence 2 registry.
  • Patients aged 75+ with ACS were selected, and their background risk was assessed using the validated Silver Code (SC) tool.
  • Multivariable logistic regression and Cox proportional hazards models analyzed PCI application rates and 1-year mortality.

Main Results:

  • PCI application decreased by 11% for each point increase in the SC score.
  • 1-year mortality hazard increased by 10% with each SC point increase.
  • PCI demonstrated a progressively greater reduction in 1-year mortality with increasing SC, indicating enhanced effectiveness in higher-risk patients.

Conclusions:

  • PCI use in older ACS patients declines as background risk increases.
  • This trend is not explained by reduced PCI effectiveness in higher-risk individuals.
  • PCI application is associated with a survival benefit that increases with higher background risk scores (SC).
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
443
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
653
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
857
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
366